Telmisartan Versus Amlodipine in Patients With Mild-to-Moderate Hypertension
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary aim of the trial is the effect of telmisartan versus amlodipine in lowering
ambulatory diastolic and/or systolic blood pressures in the last six hours of the dosing
interval in patients with mild-to-moderate hypertension as measured by ambulatory blood
pressure monitoring (ABPM)